D1 Agonist and D2 Antagonist Dual Effect of SPD 144 34. Berendsen, H.J. C, J. P. M. Postma, W. F. Gunsteren, A. DiNola, and 45. Peng, C, P. Y. Ayala, H. B. Schlegel, and M. J. Frisch. 1996. Using J. R. Haak. 1984. Molecular-dynamics with coupling to an extemal redundant internal coordinates to optimize geometries and transition bath. J. Chem. Phys. 81: 3684-3690 states.j.comp.Chem17:49-56 35. Essmannetal, U, L. Perera, M. L. Berkowitz. T. Darden, H. Lee, and 46. Case D. A.T. E. Cheatham Ill. T Darden. H. Gohlke R. Luo K. M. L. G. Pedersen. 1995. A smooth particle mesh Ewald method.J. Chem Merz, B. Wang, and R. Woods. 2005. The amber biomolecular simula- Phys.103:8577-8593 tionprogramsJ.compuTatChem.26:1668-1688 36. Xuan, J C, G. D. Lin, G. Z. Jin, and Y. Chen. 1988. Relevance of 47. Amadei. A. A. B. Linssen, and H. J. Berendsen. 1993. Essential ereo and quantum chemistry of four tetrahydroprotoberberines to dynamics of proteins. Proteins. 17: 412-42 their effects on dopamine receptors. Acta Pharmacol Sin. 9: 197-205. 48. Roth. B L. M. Shoham, M. S. Choudhary, and NKhan. 1997.Iden- Morris, G. M, D. S. Goodsell, R. S. Halliday, R. Huey, w.E. Hart tion of conserved aromatic residues essential for agonist binding R. K. Belew. and A.J. Olson. 1998. Automated docking d second messenger production at 5-hydroxytryptamine 2A receptors Lamarckian genetic algorithm and an empirical binding fre Mol. Pharmacol. 52: 259-266 function.. Compur 49. Woodward, R, S. J. Daniell, P. G. Strange, and L. H. Naylor. 1994 38. Laskowski R.A. M. w. Mac Arthur D. S. Moss and J M. Thorton. 1993. PROCHECK: a program to check the stereochemical quality of residue specifically affects the binding of a subgroup of substituted protein structures. J. App/. Crystallogr. 26: 283-291 benzamide.. Neurochem. 62: 1664-1669 39. Vriend, G, and C Sander. 1993. Quality control of protein models: di 50. Javitch, J. A. J. A. Ballesteros, H. Weinstein, and J. Chen. 1998. A tional atomic contact analysis. J. Appl. Crystallogr. 26: 47-60. cluster of aromatic residues in the sixth membrane-spanning segment 40.Co gsen, A. Spanoyannis, R. L Neve, and K.A. of the dopamine D2 receptor is accessible in the binding-site crevice. Neve. 1992. Contributions of conserved serine residues in TM5 to the Biochmestry. 37: 998-1006. ractions of ligands with dopamine D2 receptors. J Neurochem. 51. Lundstrom, K, M.P. Turpin, C. Large, G. Robertson, P.Thomas, and X Q 59:627-635 Lewell. 1998. Mapping of dopamine D3 receptor binding site by pharma 41. Iwasiow. R. M. M. F Nantel and M. Tiber. 1999. Delineation of the cological characterization of mutants expressed in CHO cells with the structural basis for the activation properties of the dopamine DI recep- emliki forest virus system. J. Recept. Signal Transduct Res. 18: 133-150 or subtypes. J. Biol. Chem. 274: 31882-31890 52. Gether, U. and B K. Kobilka. 1998. G protein-coupled 42. Mo, Y.Q., X. L. Jin, Y. T. Chen, G. Z Jin, and w.x. Shi. 2005. Mechanism of agonist activation. J. Biol. Chem. 273: 17979-17982 Effects of I-stepholidine on forebrain 53. Grobner, G, U. Burnett. C. Glaubitz. G. Cho, A.J. Bason, and A. clozapine and haloperidol Neuropsychopharmacology. 30: 261-267 /atts. 2000. Observations of light-induced structural changes of retinal 43. Xu. S.X. L. P. Yu. Y.R. Han. Y Chen and G. Z Jin. 1989. Effects thin rhodopsin Nature. 405: 810-813 mine receptor subtypes in brain. 54. Shapiro, D.A.K.Kristiansen,W.K.Kroeze,and BL.Roth Zhongguo Yao Li Xue Bao. 10: 104-110. Differential modes of agonist binding to 5-hydroxytryptamine 2A 44. Dong. Z. J. X. Guo. L. J. Chen. Y. F. Han. and G. Z. Jin. 1997. erotonin receptors revealed by mutation and molecular modeling of Dual actions of (Stepholidine on the dopamine receptor-mediated 5 Mol. Pharn se activity in rat corpus striatum. Life Sci. 61: 465-472. Biophysical Joumal 93(5)1431-144134. Berendsen, H. J. C., J. P. M. Postma, W. F. Gunsteren, A. DiNola, and J. R. Haak. 1984. Molecular-dynamics with coupling to an external bath. J. Chem. Phys. 81:3684–3690. 35. Essmannetal, U., L. Perera, M. L. Berkowitz, T. Darden, H. Lee, and L. G. Pedersen. 1995. A smooth particle mesh Ewald method. J. Chem. Phys. 103:8577–8593. 36. Xuan, J. C., G. D. Lin, G. Z. Jin, and Y. Chen. 1988. Relevance of stereo and quantum chemistry of four tetrahydroprotoberberines to their effects on dopamine receptors. Acta Pharmacol. Sin. 9:197–205. 37. Morris, G. M., D. S. Goodsell, R. S. Halliday, R. Huey, W. E. Hart, R. K. Belew, and A. J. Olson. 1998. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem. 19:1639–1662. 38. Laskowski, R. A., M. W. MacArthur, D. S. Moss, and J. M. Thornton. 1993. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26:283–291. 39. Vriend, G., and C. Sander. 1993. Quality control of protein models: direc￾tional atomic contact analysis. J. Appl. Crystallogr. 26:47–60. 40. Cox, B. A., R. A. Henningsen, A. Spanoyannis, R. L. Neve, and K. A. Neve. 1992. Contributions of conserved serine residues in TM5 to the interactions of ligands with dopamine D2 receptors. J. Neurochem. 59:627–635. 41. Iwasiow, R. M., M. F. Nantel, and M. Tiberi. 1999. Delineation of the structural basis for the activation properties of the dopamine D1 recep￾tor subtypes. J. Biol. Chem. 274:31882–31890. 42. Mo, Y. Q., X. L. Jin, Y. T. Chen, G. Z. Jin, and W. X. Shi. 2005. Effects of I-stepholidine on forebrain Fos expression: comparison with clozapine and haloperidol. Neuropsychopharmacology. 30:261–267. 43. Xu, S. X., L. P. Yu, Y. R. Han, Y. Chen, and G. Z. Jin. 1989. Effects of tetrahydroprotoberberines on dopamine receptor subtypes in brain. Zhongguo Yao Li Xue Bao. 10:104–110. 44. Dong, Z. J., X. Guo, L. J. Chen, Y. F. Han, and G. Z. Jin. 1997. Dual actions of ()–stepholidine on the dopamine receptor-mediated adenylate cyclase activity in rat corpus striatum. Life Sci. 61:465–472. 45. Peng, C., P. Y. Ayala, H. B. Schlegel, and M. J. Frisch. 1996. Using redundant internal coordinates to optimize geometries and transition states. J. Comp. Chem. 17:49–56. 46. Case, D. A., T. E. Cheatham III, T. Darden, H. Gohlke, R. Luo, K. M. Merz, B. Wang, and R. Woods. 2005. The amber biomolecular simula￾tion programs. J. Computat. Chem. 26:1668–1688. 47. Amadei, A., A. B. Linssen, and H. J. Berendsen. 1993. Essential dynamics of proteins. Proteins. 17:412–425. 48. Roth, B. L., M. Shoham, M. S. Choudhary, and N. Khan. 1997. Iden￾tification of conserved aromatic residues essential for agonist binding and second messenger production at 5-hydroxytryptamine2A receptors. Mol. Pharmacol. 52:259–266. 49. Woodward, R., S. J. Daniell, P. G. Strange, and L. H. Naylor. 1994. Structural studies on D2 dopamine receptors: mutation of a histidine residue specifically affects the binding of a subgroup of substituted benzamide. J. Neurochem. 62:1664–1669. 50. Javitch, J. A., J. A. Ballesteros, H. Weinstein, and J. Chen. 1998. A cluster of aromatic residues in the sixth membrane-spanning segment of the dopamine D2 receptor is accessible in the binding-site crevice. Biochmestry. 37:998–1006. 51. Lundstrom, K., M. P.Turpin,C. Large,G. Robertson, P. Thomas, and X. Q. Lewell. 1998. Mapping of dopamine D3 receptor binding site by pharma￾cological characterization of mutants expressed in CHO cells with the semliki forest virus system. J. Recept. Signal Transduct. Res. 18:133–150. 52. Gether, U., and B. K. Kobilka. 1998. G protein-coupled receptors: II. Mechanism of agonist activation. J. Biol. Chem. 273:17979–17982. 53. Grobner, G., U. Burnett, C. Glaubitz, G. Cho, A. J. Bason, and A. Watts. 2000. Observations of light-induced structural changes of retinal within rhodopsin. Nature. 405:810–813. 54. Shapiro, D. A., K. Kristiansen, W. K. Kroeze, and B. L. Roth. 2000. Differential modes of agonist binding to 5-hydroxytryptamine2A serotonin receptors revealed by mutation and molecular modeling of conserved residues in transmembrane region 5. Mol. Pharmacol. 58: 877–886. D1 Agonist and D2 Antagonist Dual Effect of SPD 1441 Biophysical Journal 93(5) 1431–1441